Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nityam Rathi

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Urology Practice|March 19, 2025
Editorial CommentaryNityam Rathi
Bladder Cancer (Amsterdam, Netherlands)|November 4, 2024
Device-Assisted Therapy in Non-Muscle-Invasive Bladder CancerSandeep Gurram, Nityam Rathi
Urology|December 8, 2024
Reply to Editorial Comment on "Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism"Sandeep Gurram, Nityam Rathi
Annals of Surgical Oncology|November 17, 2023
ASO Author Reflections: Predicting New Baseline Renal Function After Partial Nephrectomy: The Importance of Accuracy, Conceptual Simplicity, and Clinical PracticalityNityam Rathi, Steven C Campbell
European Urology|May 15, 2024
Predicting Renal Function following Nephroureterectomy can Impact Timing of Systemic ChemotherapyCarlos Munoz-Lopez, Nityam Rathi, Steven C Campbell
European Urology Open Science|September 8, 2022
Partial Nephrectomy for Metastatic Renal Cell Carcinoma: ProSteven C Campbell, Moshe C Ornstein, Nityam Rathi
Urology|July 5, 2021
A Bosniak IV Cystic Renal Mass with Mixed Epithelial and Stromal Tumor FeaturesNityam Rathi, Shetal N Shah, Christopher G Przybycin
Cancer Management and Research|June 18, 2020
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular CarcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Translational Cancer Research|February 4, 2022
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Current Opinion in Urology|August 18, 2017
Novel androgen axis systemic therapies for metastatic hormone-sensitive prostate cancerAndrew W Hahn, Peter Hale, Nityam Rathi, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Urology Practice|March 19, 2025
Editorial CommentaryNityam Rathi
Bladder Cancer (Amsterdam, Netherlands)|November 4, 2024
Device-Assisted Therapy in Non-Muscle-Invasive Bladder CancerSandeep Gurram, Nityam Rathi
Urology|December 8, 2024
Reply to Editorial Comment on "Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism"Sandeep Gurram, Nityam Rathi
Annals of Surgical Oncology|November 17, 2023
ASO Author Reflections: Predicting New Baseline Renal Function After Partial Nephrectomy: The Importance of Accuracy, Conceptual Simplicity, and Clinical PracticalityNityam Rathi, Steven C Campbell
European Urology|May 15, 2024
Predicting Renal Function following Nephroureterectomy can Impact Timing of Systemic ChemotherapyCarlos Munoz-Lopez, Nityam Rathi, Steven C Campbell
European Urology Open Science|September 8, 2022
Partial Nephrectomy for Metastatic Renal Cell Carcinoma: ProSteven C Campbell, Moshe C Ornstein, Nityam Rathi
Urology|July 5, 2021
A Bosniak IV Cystic Renal Mass with Mixed Epithelial and Stromal Tumor FeaturesNityam Rathi, Shetal N Shah, Christopher G Przybycin
Cancer Management and Research|June 18, 2020
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular CarcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Translational Cancer Research|February 4, 2022
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Current Opinion in Urology|August 18, 2017
Novel androgen axis systemic therapies for metastatic hormone-sensitive prostate cancerAndrew W Hahn, Peter Hale, Nityam Rathi, et al.
Pageof 8